Cycling Linked to Reduced All-Cause, CVD Mortality in Diabetes
Multivariable-adjusted hazard ratios for all-cause mortality reduced for one to 59, 60 to 149, 150 to 299, and ≥300 minutes/week
Rates of Adverse Events Lower With Apixaban for A-Fib in Older Adults
Apixaban the only direct oral anticoagulant linked to lower adverse event rates than warfarin for patients with atrial fibrillation across frailty levels
Intensive BP Control After ICH May Be Risky for Some Patients
Intensive BP lowering after intracerebral hemorrhage linked to poorer outcomes in patients with decreased renal function
Testosterone Therapy for Hypogonadism May Cut Risk for CV Events
Risk for myocardial infarction or stroke lower with testosterone therapy among men with hypogonadism and other cardiovascular risk factors
Greater Daily Coffee Intake May Lower Risk for Arrhythmia
No evidence of effect modification seen in interaction analyses using polygenic score with seven polymorphisms, CYP1A2 rs762551 alone
Non-Antimicrobial Drugs Tied to Drug-Resistant Bacterial Infection
Proton pump inhibitors, beta-blockers, antimetabolites linked to infection with antibiotic-resistant bacteria
Almost Half of Patients Admitted With COVID-19 Have Complications
Likelihood of having complications higher for men than women and for those aged older than 60 years
Review: Benefit Outweighs Harm of Statins for Primary Prevention of CVD
Risk for adverse events attributable to statins low when used for primary prevention of cardiovascular disease
AHA Addresses Diagnosis, Management of Pediatric Myocarditis
Acute myocarditis commonly has an infectious cause, most often viral; myocarditis in children presents as several distinct clinical profiles
Methamphetamine-Linked Heart Failure Up in California
Increase of 585 percent seen in methamphetamine-associated cardiomyopathy/heart failure hospitalizations from 2008 to 2018
